Fady Sayed Youssef

Dr. Fady Sayed Youssef

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
EMEman Jassim Mohammed
Eman Jassim Mohammed
AAAhmed E. M. Abdelaziz
Ahmed E. M. Abdelaziz
AMAlsayed E Mekky
Alsayed E Mekky
NMNashaat N. Mahmoud
Nashaat N. Mahmoud
Mohamed SharafMohamed Sharaf
Mohamed Sharaf
ASAly Atef Shoun
Aly Atef Shoun
This study utilized Aspergillus flavus to produce selenium nanoparticles (Se-NPs) in an environmentally friendly and ecologically sustainable manner, targeting several medicinal applications. These biosynthesized Se-NPs were meticulously characterized using X-ray diffraction (XRD), Fourier-transform infrared (FT-IR) spectroscopy, transmission electron microscope (TEM), and UV–visible spectroscopy (UV), revealing their spherical shape and size ranging between 28 and 78 nm. We conducted further testing of Se-NPs to evaluate their potential for biological applications, including antiviral, anticancer, antibacterial, antioxidant, and antibiofilm activities. The results indicate that biosynthesized Se-NPs could be effective against various pathogens, including Salmonella typhimurium (ATCC 14028), Bacillus pumilus (ATCC 14884), Staphylococcus aureus (ATCC 6538), Clostridium sporogenes (ATCC 19404), Escherichia coli (ATCC 8739), and Bacillus subtilis (ATCC 6633). Additionally, the biosynthesized Se-NPs exhibited anticancer activity against three cell lines: pancreatic carcinoma (PANC1), cervical cancer (Hela), and colorectal adenocarcinoma (Caco-2), with IC50 values of 177, 208, and 216 μg/mL, respectively. The nanoparticles demonstrated antiviral activity against HSV-1 and HAV, achieving inhibition rates of 66.4% and 15.1%, respectively, at the maximum non-toxic concentration, while also displaying antibiofilm and antioxidant properties. In conclusion, the biosynthesized Se-NPs by A. flavus present a promising avenue for various biomedical applications with safe usage.

10 March 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NTNoha Madbouly Taha
Noha Madbouly Taha
FYFady Sayed Youssef
Fady Sayed Youssef
HAHend M. Auda
Hend M. Auda
MEMohamed M. El-Bahy
Mohamed M. El-Bahy
RRReem Montasser Ramadan
Reem Montasser Ramadan
Trichinellosis is a worldwide zoonotic disease. The majority of currently available anti-trichinellosis medications exhibit inadequate efficacy. The efficacy of a natively prepared new formulation of silver nanoparticles (Ag-NPs) was evaluated in the treatment of Trichinella spiralis (T. spiralis) infection in mice alone and combined with multivitamin-mineral (MM). After investigating the product’s biological and pharmacological characteristics, its therapeutic dose was estimated to be Ag-NPs at 21.5 mg/kg B.W. This dose was orally inoculated to experimentally infected mice at 3–5 days post-inoculation (dpi) against the mature worms, at 8–10 dpi against the newborn larvae, and at 33–35th dpi against the encapsulated larvae. Each treatment’s efficacy was assessed by scarifying control and treated mice 3 days post-treatment. The drug alone or in supplement form has a high trichinocidal effect exceeding that of the reference drug. Early treatment (3–5 dpi) by Ag-NPs or Ag-NPs + MM and albendazole revealed high efficacy against the intestinal stage, reaching 93.3%, 94.7%, and 90.6% for the three treatments, respectively. The materials causing a significant (P-value < 0.001) decrease in the mean encapsulated larvae reached 86.61%, 89.07%, and 88.84%/gm of muscles using the three treatments, respectively. Moreover, all larvae extracted from Ag-NPs-treated groups failed to induce infection post-inoculation in new mice. Additionally, combining the material with MM proved to overcome the reversible adverse effects of silver material on the estimated redox parameters and liver and kidney biomarkers, denoting its ability to alleviate Ag-NP toxicity. In conclusion, the high trichinocidal effect of Ag-NPs against the adult and encapsulated larvae during a short inoculation period introduced Ag-NPs as an alternative to other nematicidal drugs.

1 January 2024 in Egyptian Journal of Veterinary Sciences
Verified
Journal Article
Open access
PDF file
FYFady Sayed Youssef
Fady Sayed Youssef
Sameh Hamed IsmailSameh Hamed Ismail
Sameh Hamed Ismail
OFOmar A. Fouad
Omar A. Fouad
GMGehad G. Mohamed
Gehad G. Mohamed
In the past ten years, biomedical nanomaterials have attracted a lot of attention. Because of their extensive and significant biological features and biomedical uses, they have underlined several issues. There are many medical applications for metal oxide nanoparticles, including antibacterial, drug/gene delivery, anticancer, cell imaging, and biosensing. In recent years, a variety of industries, including the pharmaceutical, cosmetic, concrete, antibacterial, and textile industries, as well as the automotive industry, have used zinc oxide nanoparticles (ZnO NPs) as a major material. The potential of ZnO NPs to create reactionary oxygen species and initiate cell programmed (apoptosis) is associated with anticancer and antibacterial activities. So, in order to meet the increased demand for ZnO NPs, numerous synthetic techniques have been used to produce them. There is now a search for additional alternatives with environmental and financial advantages due to the economic and environmental costs associated with the majority of ZnO NP production methods. It's interesting that the biological technique of synthesis, which uses plants, plant extracts, or microbes as sources, has been proven suitable for the creation of ZnO NPs because of its multiple medical, health, environmental, and economic advantages. This review summarized the most current developments in the synthesis and biomedical uses of ZnO NPs made using green synthesis.

1 May 2024 in Egyptian Journal of Veterinary Sciences
Verified
Journal Article
Open access
PDF file
AMAbd-Elhafeez Maha
Abd-Elhafeez Maha
MAMahmoud Arafa
Mahmoud Arafa
FAFatma Amro
Fatma Amro
FYFady Sayed Youssef
Fady Sayed Youssef
Green Chemistry (GC) is designing chemical processes and products to decrease the use of harmful materials, based on 12 theories established in 1998. The pharmaceutical industry faces a significant problem due to the worldwide requirement to comply with Green Analytical Chemistry (GAC) requirements. High-pressure liquid chromatography (HPLC) is a widely used process in the medicine industry, but it produces massive quantities of organic hazardous waste. Analytical techniques must be optimized for precision, sensitivity, repeatability, effortlessness, cost effectiveness, versatility, and speed. Though, other factors such as analysts’ security and ecological effects are rarely considered. Although there are more publications about green chromatography techniques, there has not been much adoption of eco-friendly HPLC techniques in the pharmaceutical business. The major causes of this are the need for adapting the standard HPLC apparatus, a lack of time, knowledge, or analysts' confusion over the fulfilment of the method requirements. An overview of green approaches for liquid chromatography (LC) that may be quickly applied to traditional instruments was provided to create eco-friendly HPLC procedures for pharmaceutical analysis.

21 March 2024 in Medicina
Verified
Journal Article
Open access
PDF file
AMAlsayed E Mekky
Alsayed E Mekky
AAAhmed E. M. Abdelaziz
Ahmed E. M. Abdelaziz
FYFady Sayed Youssef
Fady Sayed Youssef
SEShymaa A. Elaskary
Shymaa A. Elaskary
ASAly Atef Shoun
Aly Atef Shoun
MAMohamed Khedr Abdelgaleel
Mohamed Khedr Abdelgaleel
Background and Objectives: Urinary tract infections [UTIs] are considered the third most known risk of infection in human health around the world. There is increasing appreciation for the pathogenicity of Gram-positive and Gram-negative strains in UTIs, aside from fungal infection, as they have numerous virulence factors. Materials and Methods: In this study, fifty urine samples were collected from patients suffering from UTI. Among the isolates of UTI microbes, six isolates were described as MDR isolates after an antibiotic susceptibility test carried out using ten different antibiotics. An alternative treatment for microbial elimination involved the use of biosynthesized silver nanoparticles (AgNPs) derived from Solanum lycopersicum [S. cumin]. Results: The sizes and shapes of AgNPs were characterized through TEM imaging, which showed spherical particles in a size range of 35–80 nm, of which the average size was 53 nm. Additionally, the silver nanoparticles (AgNPs) demonstrated inhibitory activity against Staphylococcus aureus (OR648079), exhibiting a 31 mm zone of inhibition at a minimum inhibitory concentration (MIC) of 4 mg/mL and a minimum bactericidal concentration (MBC) of 8 mg/mL. This was followed by Aspergillus niger (OR648075), which showed a 30 mm inhibition zone at an MIC of 16 mg/mL and a minimum fungicidal concentration (MFC) of 32 mg/mL. Then, Enterococcus faecalis (OR648078), Klebsiella pneumoniae (OR648081), and Acinetobacter baumannii (OR648080) each displayed a 29 mm zone of inhibition at an MIC of 8 mg/mL and an MBC of 16 mg/mL. The least inhibition was observed against Candida auris (OR648076), with a 25 mm inhibition zone at an MIC of 16 mg/mL and an MFC of 32 mg/mL. Furthermore, AgNPs at different concentrations removed DPPH and H2O2 at an IC50 value of 13.54 μg/mL. Also, AgNPs at 3 mg/mL showed remarkable DNA fragmentation in all bacterial strains except Enterococcus faecalis. The phytochemical analysis showed the presence of different active organic components in the plant extract, which concluded that rutin was 88.3 mg/g, garlic acid was 70.4 mg/g, and tannic acid was 23.7 mg/g. Finally, AgNPs concentrations in the range of 3–6 mg/mL showed decreased expression of two of the fundamental genes necessary for biofilm formation within Staphylococcus aureus, fnbA (6 folds), and Cna (12.5 folds) when compared with the RecA gene, which decreased by one-fold when compared with the control sample. These two genes were submitted with NCBI accession numbers [OR682119] and [OR682118], respectively. Conclusions: The findings from this study indicate that biosynthesized AgNPs from Solanum lycopersicum exhibit promising antimicrobial and antioxidant properties against UTI pathogens, including strains resistant to multiple antibiotics. This suggests their potential as an effective alternative treatment for UTIs. Further research is warranted to fully understand the mechanisms of action and to explore the therapeutic applications of these nanoparticles in combating UTIs.

22 July 2025 in Reproductive Toxicology
Verified
Journal Article
Closed access
MBManal R Bakeer
Manal R Bakeer
MRMaha Rashad
Maha Rashad
FYFady Sayed Youssef
Fady Sayed Youssef
OAOmaima Ahmed
Omaima Ahmed
SSSeham Samir Soliman
Seham Samir Soliman
GAGhada E. Ali
Ghada E. Ali